Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hepatitis C in the rituximab era

Similar presentations


Presentation on theme: "Hepatitis C in the rituximab era"— Presentation transcript:

1 Hepatitis C in the rituximab era
by James M. Foran Blood Volume 116(24): December 9, 2010 ©2010 by American Society of Hematology

2 Grade III elevation of transaminases following 6 cycles of R-CHOP for advanced grade III follicular lymphoma in a patient treated at the University of Alabama at Birmingham with chronic HCV infection and elevated HCV viral load (> 107 copies/mL). Grade III elevation of transaminases following 6 cycles of R-CHOP for advanced grade III follicular lymphoma in a patient treated at the University of Alabama at Birmingham with chronic HCV infection and elevated HCV viral load (> 107 copies/mL). The albumin and bilirubin remained normal throughout therapy. The patient did not receive further antiviral therapy and the transaminases normalized after approximately 2 years. James M. Foran Blood 2010;116: ©2010 by American Society of Hematology


Download ppt "Hepatitis C in the rituximab era"

Similar presentations


Ads by Google